ArticleFrontiers in immunology2025

Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide.

Qi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.